• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺动脉高压治疗的新策略:促进细胞凋亡。

Novel strategy for treatment of pulmonary arterial hypertension: enhancement of apoptosis.

机构信息

Pediatric Center of Cardiac Surgery, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, 100037, Beijing, China.

出版信息

Lung. 2010 Jun;188(3):179-89. doi: 10.1007/s00408-010-9233-8. Epub 2010 Mar 6.

DOI:10.1007/s00408-010-9233-8
PMID:20213196
Abstract

Advanced pulmonary arterial hypertension is characterized by extensive vascular remodeling that is usually resistant to vasodilator therapy. As the major component of the vascular media, decreased apoptosis of pulmonary arterial smooth muscle cell (PASMC) plays key roles during pulmonary vascular remodeling. Recent studies showed that enhancement of apoptosis of PASMC can reverse pulmonary vascular remodeling and severe pulmonary arterial hypertension. Enhancement of apoptosis of PASMC is becoming a novel strategy to reverse severe pulmonary arterial hypertension. This review analyzes some potential strategies to reverse pulmonary vascular remodeling.

摘要

特发性肺动脉高压的特征是广泛的血管重构,通常对血管扩张剂治疗有抗性。作为血管中层的主要成分,肺动脉平滑肌细胞(PASMC)的凋亡减少在肺血管重构中起着关键作用。最近的研究表明,增强 PASMC 的凋亡可以逆转肺血管重构和严重的肺动脉高压。增强 PASMC 的凋亡正在成为逆转严重肺动脉高压的一种新策略。本综述分析了一些逆转肺血管重构的潜在策略。

相似文献

1
Novel strategy for treatment of pulmonary arterial hypertension: enhancement of apoptosis.肺动脉高压治疗的新策略:促进细胞凋亡。
Lung. 2010 Jun;188(3):179-89. doi: 10.1007/s00408-010-9233-8. Epub 2010 Mar 6.
2
Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.二氯乙酸通过诱导肺动脉平滑肌细胞凋亡来预防和逆转肺动脉高压。
Circ Res. 2004 Oct 15;95(8):830-40. doi: 10.1161/01.RES.0000145360.16770.9f. Epub 2004 Sep 16.
3
Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension.去氢表雄酮:一种治疗血管重构疾病的新方法,包括肺动脉高压。
Pharmacol Ther. 2010 May;126(2):186-99. doi: 10.1016/j.pharmthera.2010.02.003. Epub 2010 Mar 4.
4
Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility.环氧化酶-2抑制与缺氧诱导的肺动脉高压:对肺血管重塑和收缩性的影响。
Trends Cardiovasc Med. 2009 Feb;19(2):31-7. doi: 10.1016/j.tcm.2009.04.003.
5
Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.缺氧或血小板衍生生长因子BB依赖的桩蛋白酪氨酸磷酸化在肺动脉高压中可通过缺氧诱导因子-1α缺失或伊马替尼治疗而逆转。
Thromb Haemost. 2014 Dec;112(6):1288-303. doi: 10.1160/TH13-12-1031. Epub 2014 Sep 18.
6
P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.P21 依赖性一氧化碳释放分子-3 在肺动脉高压中的保护作用。
Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):304-12. doi: 10.1161/ATVBAHA.113.302302. Epub 2013 Dec 12.
7
[Update: Preclinical developments for the treatment of pulmonary arterial hypertension].[更新:肺动脉高压治疗的临床前进展]
Dtsch Med Wochenschr. 2009 Aug;134 Suppl 5:S157-9. doi: 10.1055/s-0029-1225313. Epub 2009 Aug 28.
8
An evidence-based approach to the management of pulmonary arterial hypertension.一种基于证据的肺动脉高压管理方法。
Curr Opin Cardiol. 2006 Jul;21(4):385-92. doi: 10.1097/01.hco.0000231410.07426.9b.
9
The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension.细胞凋亡在肺动脉高压发病机制及治疗中的关键作用。
Eur J Cardiothorac Surg. 2006 Sep;30(3):499-507. doi: 10.1016/j.ejcts.2006.05.026. Epub 2006 Jul 25.
10
Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human.肺动脉高压药物抗增殖和血管舒张作用的比较分析:大鼠和人体的广泛体外研究。
Vascul Pharmacol. 2024 Jun;155:107371. doi: 10.1016/j.vph.2024.107371. Epub 2024 Apr 8.

引用本文的文献

1
Androgen receptor inhibitor ameliorates pulmonary arterial hypertension by enhancing the apoptosis level through suppressing the Notch3/Hes5 pathway.雄激素受体抑制剂通过抑制Notch3/Hes5信号通路提高细胞凋亡水平,从而改善肺动脉高压。
Front Pharmacol. 2025 Apr 28;16:1572489. doi: 10.3389/fphar.2025.1572489. eCollection 2025.
2
LONP1 facilitates pulmonary artery smooth muscle cell glycolytic reprogramming by degrading MPC1 in pulmonary hypertension.LONP1通过降解肺动脉高压中的MPC1促进肺动脉平滑肌细胞糖酵解重编程。
Clin Sci (Lond). 2025 May 20;139(10):CS20255922. doi: 10.1042/CS20255922.
3
Regulated vascular smooth muscle cell death in vascular diseases.

本文引用的文献

1
The safety of rosiglitazone in the treatment of type 2 diabetes.罗格列酮治疗2型糖尿病的安全性。
Expert Opin Drug Saf. 2008 Sep;7(5):579-85. doi: 10.1517/14740338.7.5.579.
2
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.存活素:有丝分裂和细胞凋亡的关键调节因子及癌症治疗的新靶点。
Clin Cancer Res. 2008 Aug 15;14(16):5000-5. doi: 10.1158/1078-0432.CCR-08-0746.
3
The cancer paradigm of severe pulmonary arterial hypertension.重度肺动脉高压的癌症模式
血管疾病中的血管平滑肌细胞的程序性死亡。
Cell Prolif. 2024 Nov;57(11):e13688. doi: 10.1111/cpr.13688. Epub 2024 Jun 14.
4
Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension.天然药物在肺动脉高压治疗中的生物活性及作用机制
Chin Med. 2022 Jan 15;17(1):13. doi: 10.1186/s13020-022-00568-w.
5
Mechanical Regulation of Apoptosis in the Cardiovascular System.机械调控心血管系统细胞凋亡
Ann Biomed Eng. 2021 Jan;49(1):75-97. doi: 10.1007/s10439-020-02659-x. Epub 2020 Nov 9.
6
MicroRNA-mediated downregulation of K channels in pulmonary arterial hypertension.微小 RNA 介导的肺动脉高压中 K 通道下调。
Am J Physiol Lung Cell Mol Physiol. 2020 Jan 1;318(1):L10-L26. doi: 10.1152/ajplung.00010.2019. Epub 2019 Sep 25.
7
Clinical comparative analysis of histidine-tryptophan-ketoglutarate solution and St. Thomas crystalloid cardioplegia: A 12-year study from a single institution.组氨酸-色氨酸-酮戊二酸溶液与圣托马斯晶体心脏停搏液的临床比较分析:来自单一机构的12年研究。
Exp Ther Med. 2017 Sep;14(3):2677-2682. doi: 10.3892/etm.2017.4814. Epub 2017 Jul 19.
8
Serum Bcl-2 values in children with pulmonary hypertension.肺动脉高压患儿的血清Bcl-2值
Pediatr Cardiol. 2015 Mar;36(3):579-83. doi: 10.1007/s00246-014-1052-x. Epub 2014 Nov 9.
9
Epigenetics: novel mechanism of pulmonary hypertension.表观遗传学:肺动脉高压的新机制。
Lung. 2013 Dec;191(6):601-10. doi: 10.1007/s00408-013-9505-1. Epub 2013 Sep 20.
10
Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells.他汀类药物对人远端肺动脉平滑肌细胞的多效作用。
Respir Res. 2011 Oct 14;12(1):137. doi: 10.1186/1465-9921-12-137.
Am J Respir Crit Care Med. 2008 Sep 15;178(6):558-64. doi: 10.1164/rccm.200709-1369PP. Epub 2008 Jun 12.
4
The Role of PPARgamma in pulmonary vascular disease.过氧化物酶体增殖物激活受体γ在肺血管疾病中的作用。
J Investig Med. 2008 Feb;56(2):518-21. doi: 10.2310/JIM.0b013e318165e921.
5
Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications.钾通道在肺动脉平滑肌细胞增殖和凋亡调控中的作用:药物治疗意义
Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S99-S111. doi: 10.1038/sj.bjp.0707635. Epub 2007 Dec 17.
6
Pathogenic mechanisms of pulmonary arterial hypertension.肺动脉高压的发病机制
J Mol Cell Cardiol. 2008 Jan;44(1):14-30. doi: 10.1016/j.yjmcc.2007.09.006. Epub 2007 Sep 20.
7
The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.肺动脉高压中活化T细胞的核因子可成为治疗靶点。
Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11418-23. doi: 10.1073/pnas.0610467104. Epub 2007 Jun 27.
8
Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.阿托伐他汀对血清素诱导的血管平滑肌细胞有丝分裂、迁移及细胞外信号调节激酶丝裂原活化蛋白激酶核转位的抑制作用。
Am J Physiol Lung Cell Mol Physiol. 2007 Aug;293(2):L463-71. doi: 10.1152/ajplung.00133.2007. Epub 2007 Jun 1.
9
Emerging therapies for pulmonary arterial hypertension.
Expert Opin Investig Drugs. 2007 Jun;16(6):803-18. doi: 10.1517/13543784.16.6.803.
10
Vasoconstrictor effect of endothelin-1 on hypertensive pulmonary arterial smooth muscle involves Rho-kinase and protein kinase C.内皮素-1对高血压性肺动脉平滑肌的血管收缩作用涉及Rho激酶和蛋白激酶C。
Am J Physiol Lung Cell Mol Physiol. 2007 Aug;293(2):L472-9. doi: 10.1152/ajplung.00101.2006. Epub 2007 Apr 27.